Monitoring propranolol treatment in periocular infantile haemangioma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-11

AUTHORS

R Burne, R Taylor

ABSTRACT

OBJECTIVE: To develop a tool for assessing amblyopic risk and monitoring the treatment effect of propranolol in periocular haemangioma management. METHODS: We present a study of nine children with periocular haemangioma who underwent propranolol treatment at York Hospital between 2009 and 2013.A proposed measure of amblyogenic risk based on the induced anisometropia resulting from a periocular haemangioma was calculated in the form of a single quantitative value, measured in dioptres. This calculation used published work and developed it to produce a new function, termed the delta defocus equivalent (DFE-∂).Refraction measurements were retrospectively collected from patients' notes in order to measure the trend of DFE-∂ over the treatment period with propranolol. RESULTS: The average DFE-∂ at commencement of propranolol was 1.54 (±0.62) D. The average at the end of treatment was 0.39 (±0.38) D. CONCLUSION: This work presents a possible tool for assessing amblyopic risk in cases of periocular infantile haemangioma. The DFE-∂ gives a measure in dioptres, which may represent the true amblyopic risk, and so be useful in supporting treatment decisions in paediatric ophthalmology. More... »

PAGES

1281-1285

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/eye.2014.237

DOI

http://dx.doi.org/10.1038/eye.2014.237

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043249771

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25323853


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenergic beta-Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amblyopia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Monitoring", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Eyelid Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemangioma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Orbital Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Propranolol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Refraction, Ocular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Visual Acuity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hull York Medical School", 
          "id": "https://www.grid.ac/institutes/grid.413631.2", 
          "name": [
            "Hull York Medical School, Heslington, York, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burne", 
        "givenName": "R", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "York Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417375.3", 
          "name": [
            "Ophthalmology Department, York Hospital, York, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Taylor", 
        "givenName": "R", 
        "id": "sg:person.01366364604.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366364604.16"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1136/bjophthalmol-2011-300047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000004025"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmc0708819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019302191"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.2011.233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025833378", 
          "https://doi.org/10.1038/eye.2011.233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0886-3350(13)80312-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026101418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9394(14)78109-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026485403"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1542/peds.2012-1691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027114703"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2012.06.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031951898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2010.07.022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034890388"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.2012.48", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037626358", 
          "https://doi.org/10.1038/eye.2012.48"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archophthalmol.2011.40", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041058827"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archopht.1991.01080010072036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049866591"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1542/pir.15-7-266", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067832558"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-11", 
    "datePublishedReg": "2014-11-01", 
    "description": "OBJECTIVE: To develop a tool for assessing amblyopic risk and monitoring the treatment effect of propranolol in periocular haemangioma management.\nMETHODS: We present a study of nine children with periocular haemangioma who underwent propranolol treatment at York Hospital between 2009 and 2013.A proposed measure of amblyogenic risk based on the induced anisometropia resulting from a periocular haemangioma was calculated in the form of a single quantitative value, measured in dioptres. This calculation used published work and developed it to produce a new function, termed the delta defocus equivalent (DFE-\u2202).Refraction measurements were retrospectively collected from patients' notes in order to measure the trend of DFE-\u2202 over the treatment period with propranolol.\nRESULTS: The average DFE-\u2202 at commencement of propranolol was 1.54 (\u00b10.62)\u2009D. The average at the end of treatment was 0.39 (\u00b10.38)\u2009D.\nCONCLUSION: This work presents a possible tool for assessing amblyopic risk in cases of periocular infantile haemangioma. The DFE-\u2202 gives a measure in dioptres, which may represent the true amblyopic risk, and so be useful in supporting treatment decisions in paediatric ophthalmology.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/eye.2014.237", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1097007", 
        "issn": [
          "0950-222X", 
          "1476-5454"
        ], 
        "name": "Eye", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "name": "Monitoring propranolol treatment in periocular infantile haemangioma", 
    "pagination": "1281-1285", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "ce0364452c7520a86406bdb1b554ce414f75723b74f3b9d7cb9fe123c0f8c447"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25323853"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8703986"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/eye.2014.237"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043249771"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/eye.2014.237", 
      "https://app.dimensions.ai/details/publication/pub.1043249771"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000426.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/eye2014237"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/eye.2014.237'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/eye.2014.237'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/eye.2014.237'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/eye.2014.237'


 

This table displays all metadata directly associated to this object as RDF triples.

196 TRIPLES      21 PREDICATES      61 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/eye.2014.237 schema:about N008da010e66347ff92c1afaa001ddad1
2 N06d43ee24d434721b64d3d2dd498870c
3 N24a809452bba47b19a978c9f94309d65
4 N379e3939273d44de8ae01ffc7fc8a219
5 N38d91bcecc7d45c6b5cad1f5b4717986
6 N47780f9feda44daf9b85ab8036f45603
7 N4d109a1ad20c45168e101fe885965463
8 N52c933638d5544f38994eb5687d04f5e
9 N6b0cbbe7e8e546598391136d4147b636
10 N6c29a1b7602f408cb5ce0611e8281870
11 N74dfb3dd148d418c8f53d4ae6dab09f0
12 N893d5a5a27d340fb90f57339f3a60110
13 Na4aaceb457674a6cb57b5c00b74aed5b
14 Na6284f13054f4f738cf870f4e9c4248d
15 Nc7ef42f788664d5fb885a94034c2730c
16 Nd09f473d4dda4c97a92312766c9d9835
17 Ne01176c1658e4cfda58916cc44a9074e
18 Ne53e4b5f1f484db9b679781dbb1d0db3
19 Nea19089455b2412d8e5cf4605a8fa11f
20 Nee342d263d3640a7bedaa5cdadf4a280
21 anzsrc-for:11
22 anzsrc-for:1117
23 schema:author N11d8ca223d39403a884dbbf7db48b5d5
24 schema:citation sg:pub.10.1038/eye.2011.233
25 sg:pub.10.1038/eye.2012.48
26 https://doi.org/10.1001/archopht.1991.01080010072036
27 https://doi.org/10.1001/archophthalmol.2011.40
28 https://doi.org/10.1016/j.ajo.2010.07.022
29 https://doi.org/10.1016/j.ajo.2012.06.021
30 https://doi.org/10.1016/s0002-9394(14)78109-7
31 https://doi.org/10.1016/s0886-3350(13)80312-4
32 https://doi.org/10.1056/nejmc0708819
33 https://doi.org/10.1136/bjophthalmol-2011-300047
34 https://doi.org/10.1542/peds.2012-1691
35 https://doi.org/10.1542/pir.15-7-266
36 schema:datePublished 2014-11
37 schema:datePublishedReg 2014-11-01
38 schema:description OBJECTIVE: To develop a tool for assessing amblyopic risk and monitoring the treatment effect of propranolol in periocular haemangioma management. METHODS: We present a study of nine children with periocular haemangioma who underwent propranolol treatment at York Hospital between 2009 and 2013.A proposed measure of amblyogenic risk based on the induced anisometropia resulting from a periocular haemangioma was calculated in the form of a single quantitative value, measured in dioptres. This calculation used published work and developed it to produce a new function, termed the delta defocus equivalent (DFE-∂).Refraction measurements were retrospectively collected from patients' notes in order to measure the trend of DFE-∂ over the treatment period with propranolol. RESULTS: The average DFE-∂ at commencement of propranolol was 1.54 (±0.62) D. The average at the end of treatment was 0.39 (±0.38) D. CONCLUSION: This work presents a possible tool for assessing amblyopic risk in cases of periocular infantile haemangioma. The DFE-∂ gives a measure in dioptres, which may represent the true amblyopic risk, and so be useful in supporting treatment decisions in paediatric ophthalmology.
39 schema:genre research_article
40 schema:inLanguage en
41 schema:isAccessibleForFree true
42 schema:isPartOf Nbaa9be25830745ce8974715dca1e2ad1
43 Ncdf45154232d4d2c83fa835ce9aba85b
44 sg:journal.1097007
45 schema:name Monitoring propranolol treatment in periocular infantile haemangioma
46 schema:pagination 1281-1285
47 schema:productId N49b25a8ba8fe43a383efe2fdadc57e3c
48 N6f612942da2f43d28c36f6499b174d98
49 N7c80c1d8e355450aae6ae20feec8689c
50 Nc3df7b9e93124f4cbad3ba89c2723277
51 Nfc49e62097754a549daa632a036e7fab
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043249771
53 https://doi.org/10.1038/eye.2014.237
54 schema:sdDatePublished 2019-04-10T17:19
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher N82e5c7c806b647ce8000ac0e0e029254
57 schema:url https://www.nature.com/articles/eye2014237
58 sgo:license sg:explorer/license/
59 sgo:sdDataset articles
60 rdf:type schema:ScholarlyArticle
61 N008da010e66347ff92c1afaa001ddad1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Orbital Neoplasms
63 rdf:type schema:DefinedTerm
64 N06d43ee24d434721b64d3d2dd498870c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Hemangioma
66 rdf:type schema:DefinedTerm
67 N11d8ca223d39403a884dbbf7db48b5d5 rdf:first N8a71e7abf9684dad8a9dccc34a39a474
68 rdf:rest N213244c8d12f48e1a5c2e15723140504
69 N213244c8d12f48e1a5c2e15723140504 rdf:first sg:person.01366364604.16
70 rdf:rest rdf:nil
71 N24a809452bba47b19a978c9f94309d65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Male
73 rdf:type schema:DefinedTerm
74 N379e3939273d44de8ae01ffc7fc8a219 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Female
76 rdf:type schema:DefinedTerm
77 N38d91bcecc7d45c6b5cad1f5b4717986 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Drug Monitoring
79 rdf:type schema:DefinedTerm
80 N47780f9feda44daf9b85ab8036f45603 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Refraction, Ocular
82 rdf:type schema:DefinedTerm
83 N49b25a8ba8fe43a383efe2fdadc57e3c schema:name nlm_unique_id
84 schema:value 8703986
85 rdf:type schema:PropertyValue
86 N4d109a1ad20c45168e101fe885965463 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Eyelid Neoplasms
88 rdf:type schema:DefinedTerm
89 N52c933638d5544f38994eb5687d04f5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Adolescent
91 rdf:type schema:DefinedTerm
92 N6b0cbbe7e8e546598391136d4147b636 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Young Adult
94 rdf:type schema:DefinedTerm
95 N6c29a1b7602f408cb5ce0611e8281870 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Infant
97 rdf:type schema:DefinedTerm
98 N6f612942da2f43d28c36f6499b174d98 schema:name readcube_id
99 schema:value ce0364452c7520a86406bdb1b554ce414f75723b74f3b9d7cb9fe123c0f8c447
100 rdf:type schema:PropertyValue
101 N74dfb3dd148d418c8f53d4ae6dab09f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Retrospective Studies
103 rdf:type schema:DefinedTerm
104 N7c80c1d8e355450aae6ae20feec8689c schema:name doi
105 schema:value 10.1038/eye.2014.237
106 rdf:type schema:PropertyValue
107 N82e5c7c806b647ce8000ac0e0e029254 schema:name Springer Nature - SN SciGraph project
108 rdf:type schema:Organization
109 N893d5a5a27d340fb90f57339f3a60110 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Child
111 rdf:type schema:DefinedTerm
112 N8a71e7abf9684dad8a9dccc34a39a474 schema:affiliation https://www.grid.ac/institutes/grid.413631.2
113 schema:familyName Burne
114 schema:givenName R
115 rdf:type schema:Person
116 Na4aaceb457674a6cb57b5c00b74aed5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Risk Assessment
118 rdf:type schema:DefinedTerm
119 Na6284f13054f4f738cf870f4e9c4248d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Propranolol
121 rdf:type schema:DefinedTerm
122 Nbaa9be25830745ce8974715dca1e2ad1 schema:issueNumber 11
123 rdf:type schema:PublicationIssue
124 Nc3df7b9e93124f4cbad3ba89c2723277 schema:name pubmed_id
125 schema:value 25323853
126 rdf:type schema:PropertyValue
127 Nc7ef42f788664d5fb885a94034c2730c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Administration, Oral
129 rdf:type schema:DefinedTerm
130 Ncdf45154232d4d2c83fa835ce9aba85b schema:volumeNumber 28
131 rdf:type schema:PublicationVolume
132 Nd09f473d4dda4c97a92312766c9d9835 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Visual Acuity
134 rdf:type schema:DefinedTerm
135 Ne01176c1658e4cfda58916cc44a9074e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Amblyopia
137 rdf:type schema:DefinedTerm
138 Ne53e4b5f1f484db9b679781dbb1d0db3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Humans
140 rdf:type schema:DefinedTerm
141 Nea19089455b2412d8e5cf4605a8fa11f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Adrenergic beta-Antagonists
143 rdf:type schema:DefinedTerm
144 Nee342d263d3640a7bedaa5cdadf4a280 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Child, Preschool
146 rdf:type schema:DefinedTerm
147 Nfc49e62097754a549daa632a036e7fab schema:name dimensions_id
148 schema:value pub.1043249771
149 rdf:type schema:PropertyValue
150 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
151 schema:name Medical and Health Sciences
152 rdf:type schema:DefinedTerm
153 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
154 schema:name Public Health and Health Services
155 rdf:type schema:DefinedTerm
156 sg:journal.1097007 schema:issn 0950-222X
157 1476-5454
158 schema:name Eye
159 rdf:type schema:Periodical
160 sg:person.01366364604.16 schema:affiliation https://www.grid.ac/institutes/grid.417375.3
161 schema:familyName Taylor
162 schema:givenName R
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366364604.16
164 rdf:type schema:Person
165 sg:pub.10.1038/eye.2011.233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025833378
166 https://doi.org/10.1038/eye.2011.233
167 rdf:type schema:CreativeWork
168 sg:pub.10.1038/eye.2012.48 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037626358
169 https://doi.org/10.1038/eye.2012.48
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1001/archopht.1991.01080010072036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049866591
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1001/archophthalmol.2011.40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041058827
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1016/j.ajo.2010.07.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034890388
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1016/j.ajo.2012.06.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031951898
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1016/s0002-9394(14)78109-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026485403
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1016/s0886-3350(13)80312-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026101418
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1056/nejmc0708819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019302191
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1136/bjophthalmol-2011-300047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000004025
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1542/peds.2012-1691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027114703
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1542/pir.15-7-266 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067832558
190 rdf:type schema:CreativeWork
191 https://www.grid.ac/institutes/grid.413631.2 schema:alternateName Hull York Medical School
192 schema:name Hull York Medical School, Heslington, York, UK
193 rdf:type schema:Organization
194 https://www.grid.ac/institutes/grid.417375.3 schema:alternateName York Hospital
195 schema:name Ophthalmology Department, York Hospital, York, UK
196 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...